{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:18:54Z","timestamp":1718756334480},"reference-count":17,"publisher":"Elsevier BV","issue":"8-9","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"am","delay-in-days":353,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.purol.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T12:25:15Z","timestamp":1688473515000},"page":"446-455","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chimioth\u00e9rapie pr\u00e9op\u00e9ratoire des tumeurs des voies excr\u00e9trices sup\u00e9rieures\u00a0: impact sur la fonction r\u00e9nale"],"prefix":"10.1016","volume":"33","author":[{"given":"P.-E.","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Masson-Lecomte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Culine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.purol.2023.06.003_bib0090","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.purol.2014.06.012","article-title":"\u00c9pid\u00e9miologie et facteurs de risque des tumeurs de la voie excr\u00e9trice urinaire sup\u00e9rieure\u00a0: revue de la litt\u00e9rature pour le rapport annuel de l\u2019Association fran\u00e7aise d\u2019urologie","volume":"24","author":"Ouzzane","year":"2014","journal-title":"Prog Urol"},{"issue":"1","key":"10.1016\/j.purol.2023.06.003_bib0095","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2020\u00a0update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2023.06.003_bib0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/MOU.0000000000000832","article-title":"Perioperative chemotherapy for upper tract urothelial carcinoma: show me the evidence","volume":"31","author":"Prad\u00e8re","year":"2021","journal-title":"Curr Opin Urol"},{"issue":"10232","key":"10.1016\/j.purol.2023.06.003_bib0105","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.purol.2023.06.003_bib0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.eururo.2010.06.029","article-title":"Changes in renal function following nephroureterectomy may affect the use of perioperative chemotherapy","volume":"58","author":"Kaag","year":"2010","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.purol.2023.06.003_bib0115","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.25043","article-title":"Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.purol.2023.06.003_bib0120","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.urolonc.2012.11.014","article-title":"Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome","volume":"32","author":"Yafi","year":"2014","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.purol.2023.06.003_bib0125","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/JU.0000000000000644","article-title":"Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma","volume":"203","author":"Margulis","year":"2020","journal-title":"J Urol"},{"issue":"19","key":"10.1016\/j.purol.2023.06.003_bib0130","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.3390\/cancers14194841","article-title":"Neoadjuvant chemotherapy before nephroureterectomy in high-risk upper tract urothelial cancer: a systematic review and meta-analysis","volume":"14","author":"Oswald","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.purol.2023.06.003_bib0135","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.purol.2023.06.003_bib0140","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.eururo.2015.08.034","volume":"69","author":"McConkey","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2023.06.003_bib0145","first-page":"e999","article-title":"Lba-17\u00a0multicenter prospective phase ii clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma","volume":"201","author":"Coleman","year":"2019","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2023.06.003_bib0150","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.eururo.2020.07.003","article-title":"Neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma: a 2020\u00a0systematic review and meta-analysis, and future perspectives on systemic therapy","volume":"79","author":"Leow","year":"2021","journal-title":"Eur Urol"},{"issue":"8","key":"10.1016\/j.purol.2023.06.003_bib0155","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.22.00763","article-title":"Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma","volume":"41","author":"Coleman","year":"2023","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.purol.2023.06.003_bib0160","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s10147-020-01650-9","article-title":"Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis","volume":"25","author":"Quhal","year":"2020","journal-title":"Int J Clin Oncol"},{"issue":"2","key":"10.1016\/j.purol.2023.06.003_bib0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clgc.2021.12.014","article-title":"Five and ten-year outcomes of neoadjuvant chemotherapy and surgery for high-risk upper tract urothelial carcinoma","volume":"20","author":"Adibi","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"22","key":"10.1016\/j.purol.2023.06.003_bib0085","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708723001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708723001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T18:24:06Z","timestamp":1718735046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708723001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":17,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1166708723001276"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2023.06.003","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimioth\u00e9rapie pr\u00e9op\u00e9ratoire des tumeurs des voies excr\u00e9trices sup\u00e9rieures\u00a0: impact sur la fonction r\u00e9nale","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}